Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

The Novel Clostridial Neurotoxin Produced by Strain IBCA10-7060 Is Immunologically Equivalent to BoNT/HA.

Fan Y, Barash JR, Conrad F, Lou J, Tam C, Cheng LW, Arnon SS, Marks JD.

Toxins (Basel). 2019 Dec 20;12(1). pii: E9. doi: 10.3390/toxins12010009.

2.

Antimicrobial Susceptibility of 260 Clostridium botulinum Type A, B, Ba, and Bf Strains and a Neurotoxigenic Clostridium baratii Type F Strain Isolated from California Infant Botulism Patients.

Barash JR, Castles JB 3rd, Arnon SS.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01594-18. doi: 10.1128/AAC.01594-18. Print 2018 Dec.

3.

Safety and immunogenicity of investigational recombinant botulinum vaccine, rBV A/B, in volunteers with pre-existing botulinum toxoid immunity.

Khouri JM, Motter RN, Arnon SS.

Vaccine. 2018 Apr 5;36(15):2041-2048. doi: 10.1016/j.vaccine.2018.02.042. Epub 2018 Feb 21.

PMID:
29475762
4.

Efficacy of Human Botulism Immune Globulin for the Treatment of Infant Botulism: The First 12 Years Post Licensure.

Payne JR, Khouri JM, Jewell NP, Arnon SS.

J Pediatr. 2018 Feb;193:172-177. doi: 10.1016/j.jpeds.2017.10.035. Epub 2017 Dec 8.

PMID:
29229452
5.

More Clinical Mimics of Infant Botulism.

Khouri JM, Payne JR, Arnon SS.

J Pediatr. 2018 Feb;193:178-182. doi: 10.1016/j.jpeds.2017.09.044. Epub 2017 Dec 8.

6.

Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.

Fan Y, Barash JR, Lou J, Conrad F, Marks JD, Arnon SS.

J Infect Dis. 2016 May 15;213(10):1606-14. doi: 10.1093/infdis/jiv770. Epub 2016 Mar 1.

7.

Molecular epidemiology of infant botulism in California and elsewhere, 1976-2010.

Dabritz HA, Hill KK, Barash JR, Ticknor LO, Helma CH, Dover N, Payne JR, Arnon SS.

J Infect Dis. 2014 Dec 1;210(11):1711-22. doi: 10.1093/infdis/jiu331. Epub 2014 Jun 12.

PMID:
24924163
8.

Arrangement of the Clostridium baratii F7 toxin gene cluster with identification of a σ factor that recognizes the botulinum toxin gene cluster promoters.

Dover N, Barash JR, Burke JN, Hill KK, Detter JC, Arnon SS.

PLoS One. 2014 May 22;9(5):e97983. doi: 10.1371/journal.pone.0097983. eCollection 2014.

9.

A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.

Barash JR, Arnon SS.

J Infect Dis. 2014 Jan 15;209(2):183-91. doi: 10.1093/infdis/jit449. Epub 2013 Oct 7.

PMID:
24106296
10.

Molecular characterization of a novel botulinum neurotoxin type H gene.

Dover N, Barash JR, Hill KK, Xie G, Arnon SS.

J Infect Dis. 2014 Jan 15;209(2):192-202. doi: 10.1093/infdis/jit450. Epub 2013 Oct 7.

PMID:
24106295
11.

Clostridium botulinum strain Af84 contains three neurotoxin gene clusters: bont/A2, bont/F4 and bont/F5.

Dover N, Barash JR, Hill KK, Davenport KW, Teshima H, Xie G, Arnon SS.

PLoS One. 2013 Apr 12;8(4):e61205. doi: 10.1371/journal.pone.0061205. Print 2013.

12.

Analysis of Clostridium botulinum serotype E strains by using multilocus sequence typing, amplified fragment length polymorphism, variable-number tandem-repeat analysis, and botulinum neurotoxin gene sequencing.

Macdonald TE, Helma CH, Shou Y, Valdez YE, Ticknor LO, Foley BT, Davis SW, Hannett GE, Kelly-Cirino CD, Barash JR, Arnon SS, Lindström M, Korkeala H, Smith LA, Smith TJ, Hill KK.

Appl Environ Microbiol. 2011 Dec;77(24):8625-34. doi: 10.1128/AEM.05155-11. Epub 2011 Oct 14.

13.

Novel structural elements within the nonproteolytic clostridium botulinum type F toxin gene cluster.

Dover N, Barash JR, Hill KK, Detter JC, Arnon SS.

Appl Environ Microbiol. 2011 Mar;77(5):1904-6. doi: 10.1128/AEM.02422-10. Epub 2010 Dec 23.

14.

Universal and specific quantitative detection of botulinum neurotoxin genes.

Hill BJ, Skerry JC, Smith TJ, Arnon SS, Douek DC.

BMC Microbiol. 2010 Oct 20;10:267. doi: 10.1186/1471-2180-10-267.

15.

Identical novel A5(B3') botulinum neurotoxin gene arrangements isolated from widely disparate geographical and patient sources suggest their independent origins.

Dover N, Barash JR, Arnon SS.

J Clin Microbiol. 2010 May;48(5):1989. doi: 10.1128/JCM.00468-10. No abstract available.

16.

Concerning the article "An infant botulism case occurred in Italy".

Fenicia L, Arnon SS.

Infez Med. 2010 Mar;18(1):55. No abstract available.

17.

Presence of soil-dwelling clostridia in commercial powdered infant formulas.

Barash JR, Hsia JK, Arnon SS.

J Pediatr. 2010 Mar;156(3):402-8. doi: 10.1016/j.jpeds.2009.09.072. Epub 2009 Dec 9.

PMID:
20004414
18.

Novel Clostridium botulinum toxin gene arrangement with subtype A5 and partial subtype B3 botulinum neurotoxin genes.

Dover N, Barash JR, Arnon SS.

J Clin Microbiol. 2009 Jul;47(7):2349-50. doi: 10.1128/JCM.00799-09. Epub 2009 May 6. No abstract available.

19.

Global occurrence of infant botulism, 1976-2006.

Koepke R, Sobel J, Arnon SS.

Pediatrics. 2008 Jul;122(1):e73-82. doi: 10.1542/peds.2007-1827.

PMID:
18595978
20.

Attomolar detection of botulinum toxin type A in complex biological matrices.

Bagramyan K, Barash JR, Arnon SS, Kalkum M.

PLoS One. 2008 Apr 30;3(4):e2041. doi: 10.1371/journal.pone.0002041.

21.

Clinical mimics of infant botulism.

Francisco AM, Arnon SS.

Pediatrics. 2007 Apr;119(4):826-8.

PMID:
17403857
22.
23.

Human botulism immune globulin for the treatment of infant botulism.

Arnon SS, Schechter R, Maslanka SE, Jewell NP, Hatheway CL.

N Engl J Med. 2006 Feb 2;354(5):462-71.

24.

First case of infant botulism caused by Clostridium baratii type F in California.

Barash JR, Tang TW, Arnon SS.

J Clin Microbiol. 2005 Aug;43(8):4280-2.

25.

Infant botulism acquired from household dust presenting as sudden infant death syndrome.

Nevas M, Lindström M, Virtanen A, Hielm S, Kuusi M, Arnon SS, Vuori E, Korkeala H.

J Clin Microbiol. 2005 Jan;43(1):511-3.

27.

Botulinum toxin as a biological weapon: medical and public health management.

Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K; Working Group on Civilian Biodefense.

JAMA. 2001 Feb 28;285(8):1059-70. Review. Erratum in: JAMA 2001 Apr 25;285(16):2081.

PMID:
11209178
28.

Extreme potency of botulinum toxin.

Schechter R, Arnon SS.

Lancet. 2000 Jan 15;355(9199):237-8. No abstract available.

PMID:
10675154
29.

Commentary: where Marco Polo meets Meckel: type E botulism from Clostridium butyricum.

Schechter R, Arnon SS.

Clin Infect Dis. 1999 Dec;29(6):1388-93. No abstract available.

PMID:
10585783
30.

A second case of infant botulism type F caused by Clostridium baratii.

Paisley JW, Lauer BA, Arnon SS.

Pediatr Infect Dis J. 1995 Oct;14(10):912-4. Review. No abstract available.

PMID:
8584326
31.

Distribution of HIV type 1 infection in childbearing women in California.

Capell FJ, Vugia DJ, Mordaunt VL, Marelich WD, Ascher MS, Trachtenberg AI, Cunningham GC, Arnon SS, Kizer KW.

Am J Public Health. 1992 Feb;82(2):254-6.

32.

Botulism immune globulin for infant botulism arrives--one year and a Gulf War later.

Schwarz PJ, Arnon SS.

West J Med. 1992 Feb;156(2):197-8. No abstract available.

33.

Clinical trial of botulism immune globulin for infant botulism.

Frankovich TL, Arnon SS.

West J Med. 1991 Jan;154(1):103. No abstract available.

34.

The large intestine as the site of Clostridium botulinum colonization in human infant botulism.

Mills DC, Arnon SS.

J Infect Dis. 1987 Dec;156(6):997-8. No abstract available.

PMID:
3316418
35.

Evaluation of the Minitek system for characterization of Bacillus species.

Sullivan NM, Mills DC, Riemann HP, Arnon SS.

Appl Environ Microbiol. 1987 Nov;53(11):2680-2.

36.

Infant botulism: anticipating the second decade.

Arnon SS.

J Infect Dis. 1986 Aug;154(2):201-6. No abstract available. Erratum in: J Infect Dis 1987 Jan;155(1):162.

PMID:
3522756
37.
38.

Breast feeding and toxigenic intestinal infections: missing links in crib death?

Arnon SS.

Rev Infect Dis. 1984 Mar-Apr;6 Suppl 1:S193-201. Review.

PMID:
6372029
39.

Rapid death of infant rhesus monkeys injected with Clostridium difficile toxins A and B: physiologic and pathologic basis.

Arnon SS, Mills DC, Day PA, Henrickson RV, Sullivan NM, Wilkins TD.

J Pediatr. 1984 Jan;104(1):34-40.

PMID:
6690674
40.

Infant botulism. A Pan-Pacific perspective.

Arnon SS.

Med J Aust. 1983 Jan 8;1(1):4-5. No abstract available.

PMID:
6571524
41.

Response to letters on infant botulism.

Arnon SS.

Pediatrics. 1982 Jun;69(6):830-1. No abstract available.

PMID:
7079057
42.

Protective role of human milk against sudden death from infant botulism.

Arnon SS, Damus K, Thompson B, Midura TF, Chin J.

J Pediatr. 1982 Apr;100(4):568-73.

PMID:
7038077
43.

Infant botulism: epidemiology and relation to sudden infant death syndrome.

Arnon SS, Damus K, Chin J.

Epidemiol Rev. 1981;3:45-66. Review. No abstract available.

PMID:
7030764
44.

Quantitative evidence of intestinal colonization by Clostridium botulinum in four cases of infant botulism.

Wilcke BW Jr, Midura TF, Arnon SS.

J Infect Dis. 1980 Apr;141(4):419-23.

PMID:
6989924
45.

Honey, infant botulism and the sudden infant death syndrome.

Arnon SS.

West J Med. 1980 Jan;132(1):58-9. No abstract available.

46.

Infant botulism.

Arnon SS.

Annu Rev Med. 1980;31:541-60. Review. No abstract available.

PMID:
6772092
47.

Guanidine in botulism.

Werner SB, Arnon SS, Chin J.

JAMA. 1979 Jul 20;242(3):237-8. No abstract available.

PMID:
448906
48.

The clinical spectrum of infant botulism.

Arnon SS, Chin J.

Rev Infect Dis. 1979 Jul-Aug;1(4):614-24.

PMID:
551512
49.

Food and environmental aspects of infant botulism in California.

Chin J, Arnon SS, Midura TF.

Rev Infect Dis. 1979 Jul-Aug;1(4):693-7.

PMID:
399377
50.

Diagnosis and management of infant botulism.

Johnson RO, Clay SA, Arnon SS.

Am J Dis Child. 1979 Jun;133(6):586-93. No abstract available.

PMID:
375717

Supplemental Content

Loading ...
Support Center